<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PERT Consortium Archives - HIT Leaders and News</title>
	<atom:link href="https://us.hitleaders.news/tag/pert-consortium/feed/" rel="self" type="application/rss+xml" />
	<link>https://us.hitleaders.news/tag/pert-consortium/</link>
	<description>Healthcare Innovations and technology news and views</description>
	<lastBuildDate>Thu, 01 Sep 2022 15:50:39 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>
	<item>
		<title>Viz.ai Receives FDA 510(k) Clearance for Automated RV/LV Analysis Algorithm</title>
		<link>https://us.hitleaders.news/media-resources/press-releases-and-announcements/37607/viz-ai-receives-fda-510k-clearance-for-automated-rv-lv-analysis-algorithm/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=viz-ai-receives-fda-510k-clearance-for-automated-rv-lv-analysis-algorithm</link>
		
		<dc:creator><![CDATA[Jason Free]]></dc:creator>
		<pubDate>Thu, 01 Sep 2022 11:48:42 +0000</pubDate>
				<category><![CDATA[Press Releases & Announcements]]></category>
		<category><![CDATA[PERT Consortium]]></category>
		<category><![CDATA[RV/LV algorithm]]></category>
		<category><![CDATA[Viz PE Solution]]></category>
		<category><![CDATA[Viz.ai]]></category>
		<guid isPermaLink="false">https://us.hitleaders.news/?p=37607</guid>

					<description><![CDATA[<p>Viz.ai, a provider of AI-powered disease detection and intelligent care coordination, announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an automated RV/LV ratio algorithm, a seamless new component of the Viz PE Solution. The algorithm is designed to quickly and accurately measure the diameter of the ventricles of the heart to provide the ratio of the maximum right ventricle (RV) diameter versus that of the left ventricle (LV). Automating this key patient risk indicator will enable care teams to respond more quickly than before.</p>
<p>The post <a href="https://us.hitleaders.news/media-resources/press-releases-and-announcements/37607/viz-ai-receives-fda-510k-clearance-for-automated-rv-lv-analysis-algorithm/">Viz.ai Receives FDA 510(k) Clearance for Automated RV/LV Analysis Algorithm</a> appeared first on <a href="https://us.hitleaders.news">HIT Leaders and News</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>

<!--
Performance optimized by W3 Total Cache. Learn more: https://www.boldgrid.com/w3-total-cache/?utm_source=w3tc&utm_medium=footer_comment&utm_campaign=free_plugin

Page Caching using Disk: Enhanced 
Content Delivery Network Full Site Delivery via cloudflare

Served from: us.hitleaders.news @ 2026-06-08 06:22:07 by W3 Total Cache
-->